By: Dr. Mercola 16 October 2010 The Food and Drug Administration said preliminary results from a study in Mexico involving GlaxoSmithKline’s Rotarix vaccine suggest an increased risk of a serious bowel problem that could be fatal. A statement posted to the FDA’s website said the study showed an increased risk of intussusception in the 31-day […]
GlaxoSmithKline Influences Experts to Boost HPV Sales
By: Christina England 15 November 2010 A few days ago, the Daily Express ran an article which stated that cancer expert Professor Peter Sasieni recommended phasing out smear tests in favour of HPV testing. The opening statement in Victoria Fletcher’s article ‘New Cancer Check To Phase Out Smear Tests’ (http://www.express.co.uk/posts/view/210613/New-cancer-check-to-phase-out-smear-tests)read : “SMEAR tests for cervical […]
GlaxoSmithKline Drops the Price of Cervarix
Source: PharmaLive 25 October 2010 Today, GlaxoSmithKline Inc. (Canada), announced its plan to reduce the cost of CERVARIX™ by 30%. The cost reduction is in response to recent research that demonstrates the relatively high price of cervical cancer vaccines, coupled with a low understanding of their protective benefits topped the list of reasons why the […]
- « Previous Page
- 1
- …
- 9
- 10
- 11